Interpace Biosciences Inc (IDXG)
3.28
+0.29
(+9.70%)
USD |
OTCM |
Nov 13, 16:00
Interpace Biosciences Price: 3.28 for Nov. 13, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 13, 2024 | 3.10 | 3.46 | 3.00 | 3.28 | 20378.00 |
Nov 12, 2024 | 2.945 | 3.04 | 2.85 | 2.99 | 15840.00 |
Nov 11, 2024 | 3.20 | 3.23 | 2.85 | 2.925 | 6937.00 |
Nov 08, 2024 | 3.45 | 3.45 | 2.70 | 3.27 | 9440.00 |
Nov 07, 2024 | 3.15 | 3.54 | 3.12 | 3.25 | 49574.00 |
Nov 06, 2024 | 2.94 | 3.025 | 2.73 | 2.895 | 4510.00 |
Nov 05, 2024 | 2.49 | 3.50 | 2.49 | 2.99 | 68734.00 |
Nov 04, 2024 | 2.50 | 2.50 | 2.44 | 2.44 | 2350.00 |
Nov 01, 2024 | 2.445 | 2.45 | 2.35 | 2.45 | 1409.00 |
Oct 31, 2024 | 2.425 | 2.50 | 2.425 | 2.45 | 3303.00 |
Oct 30, 2024 | 2.55 | 2.60 | 2.40 | 2.40 | 10250.00 |
Oct 29, 2024 | 2.622 | 2.68 | 2.49 | 2.60 | 5891.00 |
Oct 28, 2024 | 2.75 | 2.76 | 2.71 | 2.71 | 4411.00 |
Oct 25, 2024 | 2.778 | 2.778 | 2.72 | 2.72 | 3126.00 |
Oct 24, 2024 | 2.75 | 2.80 | 2.632 | 2.71 | 5227.00 |
Oct 23, 2024 | 2.85 | 2.85 | 2.80 | 2.85 | 10163.00 |
Oct 22, 2024 | 2.71 | 2.90 | 2.60 | 2.90 | 5394.00 |
Oct 21, 2024 | 2.90 | 2.93 | 2.30 | 2.701 | 9821.00 |
Oct 18, 2024 | 2.90 | 3.00 | 2.68 | 2.93 | 14896.00 |
Oct 17, 2024 | 2.48 | 3.25 | 2.48 | 3.00 | 64780.00 |
Oct 16, 2024 | 2.02 | 2.48 | 1.98 | 2.48 | 17081.00 |
Oct 15, 2024 | 2.00 | 2.045 | 2.00 | 2.02 | 1139.00 |
Oct 14, 2024 | 2.00 | 2.021 | 1.99 | 1.99 | 5620.00 |
Oct 11, 2024 | 2.017 | 2.02 | 2.005 | 2.005 | 17562.00 |
Oct 10, 2024 | 2.00 | 2.08 | 2.00 | 2.02 | 6359.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.66
Minimum
Dec 27 2022
10.55
Maximum
Feb 21 2020
3.849
Average
3.15
Median
Sep 28 2020
Price Benchmarks
Fonar Corp | 15.50 |
XWELL Inc | 1.701 |
ProPhase Labs Inc | 0.79 |
Applied DNA Sciences Inc | 0.1751 |
Veracyte Inc | 38.65 |
Price Related Metrics
PS Ratio | 0.3457 |
Price to Free Cash Flow | 5.788 |
Market Cap | 14.41M |
Operating PE Ratio | 3.248 |